Markets & Finance

Ten Consistent Performers

By David Braverman Nothing beats a stock with a solid track record, especially in a dicey market. And a strong analyst recommendation lends added appeal.

That's the thinking behind our latest screen. We looked for stocks that posted price gains in each of the last five months, from September to January inclusive. The stocks had to pass another filter: They had to be ranked either 4 STARS (accumulate) or 5 STARS (strong buy) by Standard & Poor's analysts. That means S&P expects these issues to outperform the overall market in the next 6 to 12 months -- something they've already shown themselves capable of doing.

These 10 issues emerged:

Abbott Labs (ABT)

Ball Corp. (BLL)

Ballard Power Systems (BLDP)

Choicepoint (CPS)

Commerce Bancorp (CBH)

FTI Consulting (FCN)

Gtech Holdings (GTK)

Immunex (IMNX)

RadioShack (RSH)

Wal-Mart (WMT) Braverman is senior investment officer for Standard & Poor's

Toyota's Hydrogen Man

Sponsored Financial Commentaries

Sponsored Links

Buy a link now!

blog comments powered by Disqus